Global /Canada /Financial Services /Financial Conglomerates /CYTO
chevron_leftBack
Cytophage Technologies Ltd. logo

Cytophage Technologies Ltd.

CYTO
TSXV: CYTO Delayed
0.0400CAD -38%
0.0286 USD
As of 14 June 2026, Cytophage Technologies Ltd. has a market cap of $3.15M USD, ranking #46021 globally and #2254 in Canada. It ranks #4575 in the Financial Services sector, and #835 in the Financial Conglomerates industry.
Global Rank
46021
Country Rank
2254
Sector Rank
4575
Industry Rank
835
Key Stats
Market Cap
$3.15MUSD
4.4M CAD
Enterprise Value
$3.88MUSD
5.43M CAD
EBITDA (TTM)
-$3.07MUSD
-4.3M CAD
Net Income (TTM)
-$3.27MUSD
-4.57M CAD
PB Ratio
3.8
Company Profile
Country (HQ)
Sector
Financial Services
Industry
Financial Conglomerates
CEO
Steven Theriault open_in_new
Website
cytophage.com open_in_new
warningChart data may be delayed
1d 1w 1m 3m 6m 1y
-38% -38% -38% -76% -84% -80%

News

Loading...

Markets

Exchange Ticker Price
TSX Venture Exchange
MIC: XTSX
PRIMARY
CYTO
Cytophage Technologies Ltd
ISIN: CA2328211081
TV:
SA:
YF:
GF:
BA:
MS:
0.0400 CAD
1Market cap is calculated using shares outstanding.
2Float shares are publicly tradable shares, excluding insider-held stock.

About Cytophage Technologies Ltd.

Cytophage Technologies Ltd., a biotechnology company, engages in the research, development, and commercialization bacteriophage therapies to treat bacterial infections affecting human health, animal health, and food security in Canada. It develops poultry health products under the AviPhage name; food safety products under the PhageFend name; bovine mastitis products under the BoviPhage name; and water-soluble solution for livestock producers under the FarmPhage name. The company is headquartered in Oak Bluff, Canada.

Similar Companies

Industry: Financial Conglomerates (Canada)
Name
Market Cap diff.
PE
ONEX
$6.17B
8.63B CAD
196K%
9.3
$781.87M
25K%
708.4
$641.08M
896.19M CAD
20K%
6.0
$606.94M
848.46M CAD
19K%
-
$321.61M
10K%
-
$321.34M
10K%
40.6
Industry: Financial Conglomerates (Global)
Name
Market Cap diff.
PE
INVE-A
$120.04B
1.14T SEK
4M%
5.9
402340
$71.97B
109.46T KRW
2M%
12.5
ITSA3
$30.93B
157.1B BRL
983K%
9.5
$21.94B
207.94B SEK
697K%
5.2
$18.94B
598.03B TWD
602K%
12.6
HAL
$17.79B
15.4B EUR
565K%
9.6
chevron_leftBack